Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to announce successful new study results from the long-term repeated injection group from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE